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The challenge of electronic cigarettes  
Among adults (18 years and older), the use of combustible tobacco products is the leading 
preventable cause of mortality and results in a wide range of morbidities.1 Nevertheless, social 
normalization and nicotine dependence associated with combustible tobacco use have made 
smoking cessation a very difficult undertaking.  Many people who are well aware of the adverse 
effects of combustible tobacco use continue to smoke, even in the face of grave morbidity and 
death. There are many FDA approved therapies for smoking cessation, including nicotine 
replacement modalities and other pharmaceutical drugs, yet many people are unable to quit 
smoking using these therapies.  It has been estimated that most quit attempts (79%) last for less 
than one day.2 
Since their introduction into the US market in 2006, electronic cigarettes, also known as e-
cigarettes, have been seen by many to be a powerful tool against combustible tobacco use. The 
initial optimism that surrounded e-cigarette use in the fight against smoking has been tempered 
by controversies surrounding its safety, efficacy, and the involvement of tobacco companies in 
the production and marketing of e-cigarettes.3  This has essentially led to a situation where this 
very potent tool has been left to languish while the devastating health effects of combustible 
tobacco use rages on. Many professional healthcare societies do not have clear guidelines for 
their healthcare providers when it comes to e-cigarette use as a tool for smoking cessation or 
prevention. Consequently, many healthcare providers are uncertain about how to counsel their 
patient about e-cigarettes. 
So how did we get here? The e-cigarette was invented by Hon Lik, a Chinese pharmacist, in 
2003 to help himself quit smoking after his father died from smoking.4 Consequently, the initial 
purpose of e-cigarettes was to use them as a smoking cessation tool, but its potential use as a 
smoking prevention device has always been a consideration since its invention. As a smoking 
cessation tool, e-cigarettes have been shown by multiple studies to be effective for smoking 
cessation.5 In one large trial, e-cigarettes were more effective than nicotine patch, a first line 
pharmacotherapeutic agent.6 In addition, users of e-cigarettes appear to take a personal liking to 
these devices, increasing compliance and making them unique in smoking cessation therapies by 
being able to occupy the same psychological niche that combustible cigarettes occupy.7  
Obviously, in doing so it does raise the question of replacing one evil with another, but it has 
been demonstrated that although e-cigarettes do produce harmful effects, including shortness of 
breath, exacerbation of asthma, potentially carcinogenic compounds resulting from inhalation of 
e-liquid chemicals, malfunction of delivery devices leading to injury to users and other unknown 
long-term health consequences, these are in no way near the magnitude of harm caused by the 
use of combustible tobacco cigarettes.5 
Conversely, e-cigarettes have not been shown to be an effective smoking prevention tool.  
Mounting evidence suggests that e-cigarette use, especially among youths, may lead to 
subsequent increased risk of using combustible tobacco products.8 This may be partly because of 
aggressive marketing and design of certain e-cigarette products, notably by the e-cigarette 
manufacturer JUUL, towards the youth such that they find it more appealing and easier to use 
discretely owing to its flavored content and compact physical form.  Notwithstanding, one has to 
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keep in mind that by far the largest proportion of e-cigarette users are current smokers or former 
smokers and only a small fraction of individuals who have never smoked cigarettes ever try e-
cigarettes (5.7%) or become chronic users of e-cigarettes (0.7%).9 Therefore in reality, young 
people who do not find smoking appealing  in general, appear to be unlikely to pick up the habit 
of e-cigarette smoking in the first place. 
Given the above premise, smoking cessation using e-cigarettes with complete cessation of 
combustible tobacco products should be recommended as a smoking cessation tool for current 
smokers, who have either failed to quit with the currently available smoking cessation therapies 
or are unwilling to try other therapies. This should be done with the understanding that certain 
long-term health consequences of e-cigarette use are currently unknown but are significantly less 
harmful than combustible cigarettes. This is clearly a difficult needle to thread, but one which 
has great potential to improve the health status of millions of individuals. This is the challenge of 
e-cigarettes. 
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